中国老年学杂志
中國老年學雜誌
중국노년학잡지
CHINESE JOURNAL OF GERONTOLOGY
2014年
9期
2317-2319
,共3页
魏其林%王军%黄焕新%郝传铮%顾晓松
魏其林%王軍%黃煥新%郝傳錚%顧曉鬆
위기림%왕군%황환신%학전쟁%고효송
帕金森病%非运动症状%神经生长液
帕金森病%非運動癥狀%神經生長液
파금삼병%비운동증상%신경생장액
Parkinson′s disease%Non-motor symptoms%Nerve growth decoction
目的:探讨神经生长液对帕金森病( PD)患者非运动症状( NMS)临床治疗效果。方法采用 PD 非运动症状30问卷筛查量表( NMSQuest)对48例PD患者的NMS进行评估,并选用Hoehn-Yahr(HY)分期、PD统一评分量表-3(UPDRS-3)、多巴丝肼用量作为评估患者运动功能的指标,同时结合年龄、性别、发病时间、受教育程度等可能影响患者NMS的因素评估对PD患者NMS影响的程度。结果 PD非运动症状30问卷筛查量表( NMSQuest)显示PD患者NMS极其普遍。 NMS评分与病程、UPDRS3、HY分期呈正相关。患者治疗后多巴丝肼用量、UPDRS3评分与治疗前的差异无统计学意义(P<0.05),NMSQuest得分比治疗前显著降低(P<0.05)。特别是生动梦境、不明原因的疼痛、注意力下降、失眠、便秘、头晕等症状改善明显。结论神经生长液可明显改善PD患者的NMS从而提高生活质量。
目的:探討神經生長液對帕金森病( PD)患者非運動癥狀( NMS)臨床治療效果。方法採用 PD 非運動癥狀30問捲篩查量錶( NMSQuest)對48例PD患者的NMS進行評估,併選用Hoehn-Yahr(HY)分期、PD統一評分量錶-3(UPDRS-3)、多巴絲肼用量作為評估患者運動功能的指標,同時結閤年齡、性彆、髮病時間、受教育程度等可能影響患者NMS的因素評估對PD患者NMS影響的程度。結果 PD非運動癥狀30問捲篩查量錶( NMSQuest)顯示PD患者NMS極其普遍。 NMS評分與病程、UPDRS3、HY分期呈正相關。患者治療後多巴絲肼用量、UPDRS3評分與治療前的差異無統計學意義(P<0.05),NMSQuest得分比治療前顯著降低(P<0.05)。特彆是生動夢境、不明原因的疼痛、註意力下降、失眠、便祕、頭暈等癥狀改善明顯。結論神經生長液可明顯改善PD患者的NMS從而提高生活質量。
목적:탐토신경생장액대파금삼병( PD)환자비운동증상( NMS)림상치료효과。방법채용 PD 비운동증상30문권사사량표( NMSQuest)대48례PD환자적NMS진행평고,병선용Hoehn-Yahr(HY)분기、PD통일평분량표-3(UPDRS-3)、다파사정용량작위평고환자운동공능적지표,동시결합년령、성별、발병시간、수교육정도등가능영향환자NMS적인소평고대PD환자NMS영향적정도。결과 PD비운동증상30문권사사량표( NMSQuest)현시PD환자NMS겁기보편。 NMS평분여병정、UPDRS3、HY분기정정상관。환자치료후다파사정용량、UPDRS3평분여치료전적차이무통계학의의(P<0.05),NMSQuest득분비치료전현저강저(P<0.05)。특별시생동몽경、불명원인적동통、주의력하강、실면、편비、두훈등증상개선명현。결론신경생장액가명현개선PD환자적NMS종이제고생활질량。
Objective To investigate the curative effect of nerve growth decoction ( NGD) for treatment on non-motor symptoms ( NMS) of Parkinson's disease ( PD).Methods The NMS in 48 patients with PD were estimated using the PD NMS Questionnaire.Mean-while Hoehn-Yahr(HY) scale, unified PD rating scale(UPDRS) part3, Levodopa and Benserazide tablet dosage were used to assess motor symptoms.The factors, affected the NMS in the patients, such as age, sex, time of onset, educational level and as on were also investiga-ted.NGD had been administered by 1 package/day, 1 therapy duration/30 days, and next therapy duration continued after the therapy inter-val of 1~2 weeks.The whole therapy period was 2 to 3 durations and intervals cycled as aboved.Evaluations were observed before and after treatment.Results NMSQuest showed that NMS in PD were common and frequent.There was a significant association of total NMS score with duration, UPDRS3 score and HY stage.The differences of Levodopa and Benserazide tablet dosage and UPDRS 3 score before and after treatment had not statistical significance .NMSQuest scores were significantly reduced after treatment compared to those before treatment (P<0.05).Especially the symptoms of vivid dreams , unexplained pain, attention, insomnia, constipation, dizziness and other symptoms im-proved significantly.Conclusions NGD has positive effects on NMS in PD patients and improve quality of life.